Evidence Hub

Lung-limited granulomatosis with polyangiitis and the importance of early treatment: a case report

Hamed H, Haddad S, Alabd L, Eddin HS, Alhmada Z, Elsadig R, Kabbabe GM, Albraday N

Annals of medicine and surgery (2012), 2026

Abstract

Introduction and importance: Granulomatosis with polyangiitis (GPA) is a rare systemic vasculitis causing necrotizing granulomatous inflammation, mostly affecting the respiratory tract and kidneys. It has an annual incidence of 0.3 to 1.4 per 100 000. Diagnosis is based on clinical presentation and serological findings. Treatment typically involves glucocorticoids and cyclophosphamide. This article describes a case of GPA in an elderly male with cough, hemoptysis, and bilateral hearing loss.

Case presentation: A 58-year-old man presented with hemoptysis, cough, fever, joint pain, and fatigue. Initially diagnosed with pneumonia, he showed improvements with prednisolone but experienced recurring symptoms. Examination revealed abnormal CBC, proteinuria, and positive cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA), indicating granulomatosis with polyangiitis. Due to hypoxia and alveolar hemorrhage, high-dose corticosteroid therapy was initiated, followed by rituximab, leading to significant improvement.

Clinical discussion: Granulomatosis with polyangiitis (GPA) is a rare autoimmune disease primarily affecting the upper respiratory tract, lungs, and kidneys. The disease's main inflammatory marker is c-ANCA. Treatment often involves steroids and immunosuppressants. This case emphasizes the necessity of early treatment, even without histological confirmation, due to severe symptoms like hemoptysis, hypoxia, and alveolar hemorrhage, but without renal involvement.…

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free